Black Diamond Therapeutics

BDTXNasdaq United States Health Care Biotechnology: Biological Products (No Diagnostic Substances)

Market cap

$95.660 M

$1.67 -12.37%

Close of 6 Nov 2026

As of 6 Nov 2026, Black Diamond Therapeutics (BDTX) has a market capitalization of $95.7M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

$22.4B

#17 by earnings

Shares outstanding

57,453,747

Latest filing cover page

P/E ratio

0.0

Cap ÷ net income

Biotechnology: Biological Products (No Diagnostic Substances), ranked by market cap

All 163 →

#111Voyager TherapeuticsVYGR$106.0M
#112Anavex Life SciencesAVXL$102.4M
#113Black Diamond TherapeuticsBDTX$95.7M
#114LENZ TherapeuticsLENZ$95.4M
#115Neumora TherapeuticsNMRA$92.4M

What if Black Diamond Therapeutics were worth as much as…

Open the what-if tool →

Gold $28.2T

$491,471.40

Per share 295,178× higher

Bitcoin $1.53T

$26,592.66

Per share 15,972× higher

Apple $5.02T

$87,301.23

Per share 52,433× higher

Or at a round number

$200.0M $500.0M $1.00B $2.00B

Where these numbers come from

Share counts and financials for Black Diamond Therapeutics are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.